Home » BMS’ Orencia Autoinjector Hits the Market
BMS’ Orencia Autoinjector Hits the Market
Bristol-Myers Squibb announced Wednesday it has released its new autoinjector Orencia for adults with moderate to severe rheumatoid arthritis.
Orencia comes in three different forms: IV infusion, prefilled syringe and autoinjector.
The device is indicated for reducing the signs and symptoms of RA, deterring the advancement of structural damage due to the condition, and improving mobility. — Cynthia Jessup
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May